Letrozole Femara 5mg Anabolic Steroids Liquid
What is Letrazole ?
Letrozole, sold under the brand name Femara, is a prescription drug used to treat breast cancer in its advanced stages, and in women who have finished menopause.
Doctors may use letrozole off-label in fertility treatments to help encourage egg release (ovulation) in women.
Letrozole belongs to a class of cancer drugs known as aromatase inhibitors, which work by preventing the body from converting a hormone called androgen into estrogen.
This treatment has proven beneficial in cancers whose growth seems to be encouraged by excess estrogen in the body, like certain types of breast cancer.
Dosage of Letrazole
The good results of using doses ranged from about 0.25mgs per day to 0.5mgs per day .
Also, doses reported have ranged from .25mgs to as much as 2.5mgs per day.
The maximum dosage that a user would want to use would be 2.5mgs per day. It has been shown in numerous studies that this dosage will eliminate nearly all of the estrogen in the body in nearly all individuals. Any dose that is higher than this would simply be unneeded.
Letrozole comes in tablets of 2.5 milligrams (mg).
How much letrozole your doctor tells you to take may vary, but for cancer, a usual dose is 2.5 mg a day.
If you're taking letrozole for fertility treatment, your doctor may tell you to take either 2.5 mg or 5 mg of the drug, beginning on the third day of your period for five days
Side effects :
Femara can harm an unborn baby or cause birth defects.
Femara may impair your thinking or reactions.
Hot flashes, hair loss, joint/bone/muscle pain, tiredness, unusual sweating, nausea, diarrhea, dizziness, and trouble sleeping may occur.
Primary use :
Femara lowers estrogen levels in postmenopausal women, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.
Femara is used to treat breast cancer in postmenopausal women.It is often given to women who have been taking (Nolvadex, Soltamox) for 5 years.
Femara may also be used for purposes not listed in this medication guide.
Specifications
Tests | Specifications | Results |
Appearance | White or off-white crystaline powder | White Crystalline powder |
Solubility | Soluble in Chloroform; Soluble in ethanol when heated | Conform |
ldentification | (1)Maximum absorption in wavelength of 240 nm Minimum absorption in wavelength of 215 nm | Conform Conform |
(2)Infrared spectrum should be in accordance the dominant peak of contrast | In accordance with the dominant peak of contrast | |
Melting points | 182°C-184°C | 182°C |
Related substances | ≤0.5% | 0.3% |
Single impurity | ≤0.3% | 0.2% |
Loss on drying | ≤1.0% | 0.8% |
[Assay]C17H11N5 (On anhydrous basis) | ≥98.0% | 99.2% |
Conclusion | Conforms Specifications of USP35 | |
Femara Oral Conversion Recipes
200ml @ 5 mg/ml
1 gram of powder
1 beaker suitable for holding the volume of liquids
19.9 ml of PEG 300
179.1 ml of 190 Proof Grain Alcohol
